432 related articles for article (PubMed ID: 32979316)
1. SARS-CoV-2 Infection of Pluripotent Stem Cell-Derived Human Lung Alveolar Type 2 Cells Elicits a Rapid Epithelial-Intrinsic Inflammatory Response.
Huang J; Hume AJ; Abo KM; Werder RB; Villacorta-Martin C; Alysandratos KD; Beermann ML; Simone-Roach C; Lindstrom-Vautrin J; Olejnik J; Suder EL; Bullitt E; Hinds A; Sharma A; Bosmann M; Wang R; Hawkins F; Burks EJ; Saeed M; Wilson AA; Mühlberger E; Kotton DN
Cell Stem Cell; 2020 Dec; 27(6):962-973.e7. PubMed ID: 32979316
[TBL] [Abstract][Full Text] [Related]
2. SARS-CoV-2 Infection of Pluripotent Stem Cell-derived Human Lung Alveolar Type 2 Cells Elicits a Rapid Epithelial-Intrinsic Inflammatory Response.
Huang J; Hume AJ; Abo KM; Werder RB; Villacorta-Martin C; Alysandratos KD; Beermann ML; Simone-Roach C; Lindstrom-Vautrin J; Olejnik J; Suder EL; Bullitt E; Hinds A; Sharma A; Bosmann M; Wang R; Hawkins F; Burks EJ; Saeed M; Wilson AA; Mühlberger E; Kotton DN
bioRxiv; 2020 Aug; ():. PubMed ID: 32637964
[TBL] [Abstract][Full Text] [Related]
3. SARS-CoV-2 infection of primary human lung epithelium for COVID-19 modeling and drug discovery.
Mulay A; Konda B; Garcia G; Yao C; Beil S; Villalba JM; Koziol C; Sen C; Purkayastha A; Kolls JK; Pociask DA; Pessina P; de Aja JS; Garcia-de-Alba C; Kim CF; Gomperts B; Arumugaswami V; Stripp BR
Cell Rep; 2021 May; 35(5):109055. PubMed ID: 33905739
[TBL] [Abstract][Full Text] [Related]
4. Host metabolism dysregulation and cell tropism identification in human airway and alveolar organoids upon SARS-CoV-2 infection.
Pei R; Feng J; Zhang Y; Sun H; Li L; Yang X; He J; Xiao S; Xiong J; Lin Y; Wen K; Zhou H; Chen J; Rong Z; Chen X
Protein Cell; 2021 Sep; 12(9):717-733. PubMed ID: 33314005
[TBL] [Abstract][Full Text] [Related]
5. Development of alveolar and airway cells from human iPS cells: toward SARS-CoV-2 research and drug toxicity testing.
Tsuji K; Yamada S; Hirai K; Asakura H; Kanda Y
J Toxicol Sci; 2021; 46(9):425-435. PubMed ID: 34470994
[TBL] [Abstract][Full Text] [Related]
6. Antiviral activity and safety of remdesivir against SARS-CoV-2 infection in human pluripotent stem cell-derived cardiomyocytes.
Choi SW; Shin JS; Park SJ; Jung E; Park YG; Lee J; Kim SJ; Park HJ; Lee JH; Park SM; Moon SH; Ban K; Go YY
Antiviral Res; 2020 Dec; 184():104955. PubMed ID: 33091434
[TBL] [Abstract][Full Text] [Related]
7. Single cell resolution of SARS-CoV-2 tropism, antiviral responses, and susceptibility to therapies in primary human airway epithelium.
Fiege JK; Thiede JM; Nanda HA; Matchett WE; Moore PJ; Montanari NR; Thielen BK; Daniel J; Stanley E; Hunter RC; Menachery VD; Shen SS; Bold TD; Langlois RA
PLoS Pathog; 2021 Jan; 17(1):e1009292. PubMed ID: 33507952
[TBL] [Abstract][Full Text] [Related]
8. Unlike Chloroquine, Mefloquine Inhibits SARS-CoV-2 Infection in Physiologically Relevant Cells.
Sacramento CQ; Fintelman-Rodrigues N; Dias SSG; Temerozo JR; Da Silva APD; da Silva CS; Blanco C; Ferreira AC; Mattos M; Soares VC; Pereira-Dutra F; Miranda MD; Barreto-Vieira DF; da Silva MAN; Santos SS; Torres M; Chaves OA; Rajoli RKR; Paccanaro A; Owen A; Bou-Habib DC; Bozza PT; Souza TML
Viruses; 2022 Feb; 14(2):. PubMed ID: 35215969
[TBL] [Abstract][Full Text] [Related]
9. Air-liquid interphase culture confers SARS-CoV-2 susceptibility to A549 alveolar epithelial cells.
Sasaki M; Kishimoto M; Itakura Y; Tabata K; Intaruck K; Uemura K; Toba S; Sanaki T; Sato A; Hall WW; Orba Y; Sawa H
Biochem Biophys Res Commun; 2021 Nov; 577():146-151. PubMed ID: 34517212
[TBL] [Abstract][Full Text] [Related]
10. Drug Inhibition of SARS-CoV-2 Replication in Human Pluripotent Stem Cell-Derived Intestinal Organoids.
Krüger J; Groß R; Conzelmann C; Müller JA; Koepke L; Sparrer KMJ; Weil T; Schütz D; Seufferlein T; Barth TFE; Stenger S; Heller S; Münch J; Kleger A
Cell Mol Gastroenterol Hepatol; 2021; 11(4):935-948. PubMed ID: 33186749
[TBL] [Abstract][Full Text] [Related]
11. The folate antagonist methotrexate diminishes replication of the coronavirus SARS-CoV-2 and enhances the antiviral efficacy of remdesivir in cell culture models.
Stegmann KM; Dickmanns A; Gerber S; Nikolova V; Klemke L; Manzini V; Schlösser D; Bierwirth C; Freund J; Sitte M; Lugert R; Salinas G; Meister TL; Pfaender S; Görlich D; Wollnik B; Groß U; Dobbelstein M
Virus Res; 2021 Sep; 302():198469. PubMed ID: 34090962
[TBL] [Abstract][Full Text] [Related]
12. Beneficial effect of combinational methylprednisolone and remdesivir in hamster model of SARS-CoV-2 infection.
Ye ZW; Yuan S; Chan JF; Zhang AJ; Yu CY; Ong CP; Yang D; Chan CC; Tang K; Cao J; Poon VK; Chan CC; Cai JP; Chu H; Yuen KY; Jin DY
Emerg Microbes Infect; 2021 Dec; 10(1):291-304. PubMed ID: 33538646
[TBL] [Abstract][Full Text] [Related]
13. Hamster organotypic modeling of SARS-CoV-2 lung and brainstem infection.
Ferren M; Favède V; Decimo D; Iampietro M; Lieberman NAP; Weickert JL; Pelissier R; Mazelier M; Terrier O; Moscona A; Porotto M; Greninger AL; Messaddeq N; Horvat B; Mathieu C
Nat Commun; 2021 Oct; 12(1):5809. PubMed ID: 34608167
[TBL] [Abstract][Full Text] [Related]
14. Revealing Tissue-Specific SARS-CoV-2 Infection and Host Responses using Human Stem Cell-Derived Lung and Cerebral Organoids.
Tiwari SK; Wang S; Smith D; Carlin AF; Rana TM
Stem Cell Reports; 2021 Mar; 16(3):437-445. PubMed ID: 33631122
[TBL] [Abstract][Full Text] [Related]
15. SARS-CoV-2 infects and induces cytotoxic effects in human cardiomyocytes.
Bojkova D; Wagner JUG; Shumliakivska M; Aslan GS; Saleem U; Hansen A; Luxán G; Günther S; Pham MD; Krishnan J; Harter PN; Ermel UH; Frangakis AS; Milting H; Zeiher AM; Klingel K; Cinatl J; Dendorfer A; Eschenhagen T; Tschöpe C; Ciesek S; Dimmeler S
Cardiovasc Res; 2020 Dec; 116(14):2207-2215. PubMed ID: 32966582
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of coronavirus infection by a synthetic STING agonist in primary human airway system.
Zhu Q; Zhang Y; Wang L; Yao X; Wu D; Cheng J; Pan X; Liu H; Yan Z; Gao L
Antiviral Res; 2021 Mar; 187():105015. PubMed ID: 33444702
[TBL] [Abstract][Full Text] [Related]
17. Combined computational and cellular screening identifies synergistic inhibition of SARS-CoV-2 by lenvatinib and remdesivir.
Pohl MO; Busnadiego I; Marrafino F; Wiedmer L; Hunziker A; Fernbach S; Glas I; Moroz-Omori EV; Hale BG; Caflisch A; Stertz S
J Gen Virol; 2021 Jul; 102(7):. PubMed ID: 34319869
[TBL] [Abstract][Full Text] [Related]
18. Comparison of Antiviral Activity of Gemcitabine with 2'-Fluoro-2'-Deoxycytidine and Combination Therapy with Remdesivir against SARS-CoV-2.
Jang Y; Shin JS; Lee MK; Jung E; An T; Kim UI; Kim K; Kim M
Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33557278
[TBL] [Abstract][Full Text] [Related]
19. An organoid-derived bronchioalveolar model for SARS-CoV-2 infection of human alveolar type II-like cells.
Lamers MM; van der Vaart J; Knoops K; Riesebosch S; Breugem TI; Mykytyn AZ; Beumer J; Schipper D; Bezstarosti K; Koopman CD; Groen N; Ravelli RBG; Duimel HQ; Demmers JAA; Verjans GMGM; Koopmans MPG; Muraro MJ; Peters PJ; Clevers H; Haagmans BL
EMBO J; 2021 Mar; 40(5):e105912. PubMed ID: 33283287
[TBL] [Abstract][Full Text] [Related]
20. ApoE-Isoform-Dependent SARS-CoV-2 Neurotropism and Cellular Response.
Wang C; Zhang M; Garcia G; Tian E; Cui Q; Chen X; Sun G; Wang J; Arumugaswami V; Shi Y
Cell Stem Cell; 2021 Feb; 28(2):331-342.e5. PubMed ID: 33450186
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
